Piramal Pharma gets 2 USFDA observations for Bethlehem facility Ruchika Sharma29 Sept 2023 3:30 PM ISTMumbai: Piramal Pharma has announced that the US Food and Drug Administration (USFDA) has concluded a Good Manufacturing Practices (GMP)...
Piramal Pharma gets SEBI go ahead to raise up to Rs 1050 crore through rights issue Ruchika Sharma18 July 2023 3:30 PM ISTProceeds of the issue will be utilised for payment of debt and general corporate purposes.
CDPQ divests 0.89 percent stake in Piramal Pharma for Rs 100 crore Ruchika Sharma17 Jun 2023 1:30 PM ISTVanguard Group acquired more than 62 lakh shares of Piramal Pharma at an average price of Rs 94.71 per share, while other buyer(s) identity is not...
Piramal Critical Care ropes in Jeffrey Hampton as President, COO Ruchika Sharma6 Jun 2023 5:28 PM ISTMumbai: Piramal Pharma Limited’s Piramal Critical Care (PCC) business has announced the appointment of Jeffrey Hampton as President & Chief...
USFDA successfully concludes inspection at Piramal Pharma Pithampur facility Ruchika Sharma22 May 2023 12:43 PM ISTMumbai: Piramal Pharma Limited has announced that the US Food and Drug Administration (USFDA) has successfully concluded an inspection at the...
Piramal Pharma gets USFDA EIR for Sellersville facility Ruchika Sharma19 April 2023 2:46 PM ISTMumbai: Piramal Pharma has recently announced that the US Food and Drug Administration (USFDA) has successfully concluded the inspection of the...
Piramal Pharma Digwal facility successfully concludes USFDA inspection Ruchika Sharma4 April 2023 12:11 PM ISTMumbai: Piramal Pharma Limited has recently announced that the US Food and Drug Administration (USFDA) has successfully completed the Good...
Piramal Pharma reports consolidated net loss of Rs 90 crore in Q3 Ruchika Sharma10 Feb 2023 1:15 PM ISTNew Delhi: Piramal Pharma has reported a net loss of Rs 90 crore on a consolidated basis for the third quarter ended December 31, 2022. The...
USFDA inspection: Piramal Pharma gets Form 483 with 6 observations for Lexington facility Ruchika Sharma12 Jan 2023 11:32 AM ISTThe observations were classified under VAI (Voluntary Action Indicated) and does not relate to data integrity.
India begins anti-dumping investigation into import of vitamin from China, EU Ruchika Sharma6 Jan 2023 1:30 PM ISTPiramal Pharma Ltd has filed a petition before the DGTR seeking imposition of anti-dumping duty on the imports.
Piramal Pharma Consumer Products Division unveils D2C platform Wellify.in Ruchika Sharma8 Nov 2022 2:30 PM ISTThe platform will offer free home delivery, no minimum order value, and delightful offers which will enable rise in daily orders.
Piramal Pharma gets SEBI nod to list shares on Indian stock exchanges Ruchika Sharma14 Oct 2022 11:15 AM ISTThe demerger from PEL will firmly empower PPL to be future-ready and enable it to independently pursue its growth strategies with sharper focus and...
